NorthStar Healthcare Income, Inc.
NHHS
$1.82
$0.819981.99%
| Weiss Ratings | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C | |||
| Rating Factors | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -3,707.28 | |||
| Price History | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 606,538.00% | |||
| 60-Day Total Return | 91.57% | |||
| 90-Day Total Return | 105.64% | |||
| Year to Date Total Return | 91.57% | |||
| 1-Year Total Return | 91.57% | |||
| 2-Year Total Return | 106.81% | |||
| 3-Year Total Return | 29.07% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 1,819,814.00% | |||
| Price | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.82 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 16, 2024 | |||
| 52-Week High Price (Date) | Feb 20, 2025 | |||
| Valuation | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 337.98M | |||
| Enterprise Value | 880.19M | |||
| Price/Earnings (TTM) | 10.44 | |||
| Earnings Per Share (TTM) | 0.17 | |||
| Earnings Per Share Growth | -133.17% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.66 | |||
| Price/Book (Q) | 1.41 | |||
| Enterprise Value/Revenue (TTM) | 4.33 | |||
| Price | $1.82 | |||
| Enterprise Value/EBITDA (TTM) | 14.97 | |||
| Enterprise Value/EBIT | 39.00 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 185.71M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 929 777 3135 | |||
| Address | 16 East 34th Street New York, NY 10016 | |||
| Website | www.northstarhealthcarereit.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 11.09% | |||
| Profit Margin | 15.93% | |||
| Management Effectiveness | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.23% | |||
| Return on Equity | 13.56% | |||
| Income Statement | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 148.77M | |||
| Total Revenue (TTM) | 203.39M | |||
| Revenue Per Share | $1.10 | |||
| Gross Profit (TTM) | 71.47M | |||
| EBITDA (TTM) | 58.80M | |||
| EBIT (TTM) | 22.57M | |||
| Net Income (TTM) | 32.40M | |||
| Net Income Avl. to Common (TTM) | 32.40M | |||
| Total Revenue Growth (Q YOY) | 0.84% | |||
| Earnings Growth (Q YOY) | 1,192.19% | |||
| EPS Diluted (TTM) | 0.17 | |||
| EPS Diluted Growth (Q YOY) | 1,209.44% | |||
| Balance Sheet | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 333.46M | |||
| Cash Per Share (Q) | $1.80 | |||
| Total Current Assets (Q) | 342.93M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 237.87M | |||
| Current Ratio (Q) | 0.488 | |||
| Book Value Per Share (Q) | $1.29 | |||
| Total Assets (Q) | 1.15B | |||
| Total Current Liabilities (Q) | 702.88M | |||
| Total Debt (Q) | 877.19M | |||
| Total Liabilities (Q) | 914.18M | |||
| Total Common Equity (Q) | 239.43M | |||
| Cash Flow | NHHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 247.64M | |||
| Cash from Financing (TTM) | -28.66M | |||
| Net Change in Cash (TTM) | 241.71M | |||
| Levered Free Cash Flow (TTM) | 37.35M | |||
| Cash from Operations (TTM) | 22.74M | |||
